Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 08 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-08-2022-3

Zydus Lifesciences Limited has informed the Exchange about press release dated 08-Jul-2022 titled Zydus has launched Sitaglyn�� and Siglyn�� (Sitagliptin), for the management of Type 2 diabetes

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases